TAC Stock Recent News
TAC LATEST HEADLINES
The average of price targets set by Wall Street analysts indicates a potential upside of 78.3% in TransAlta (TAC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
TransAlta (TAC) makes a strong case for investment, given its growth prospects, strong return on equity and ability to increase shareholders' value.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
While passive-income providers tend to be established large-capitalization enterprises, that's not always the case as these under-$10 dividend stocks prove. To be sure, nothing is for free on Wall Street.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Generally speaking, you want to minimize your exposure to cheap stocks under $10. Yes, smaller companies have the potential to rise dramatically higher than their larger counterparts.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
TransAlta Corporation (TAC) makes a strong case for investment, given its growth prospects, strong ROE and ability to increase shareholders' value.
TransAlta (TAC) closed at $6.87 in the latest trading session, marking a -1.01% move from the prior day.
The mean of analysts' price targets for TransAlta (TAC) points to a 72.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.